SCHEMBL8084637

SCHEMBL8084637

CCS(=O)(=O)Cc1cc(N)nc(-c2ccc(NC(=O)NC(C)C)cc2)n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 3/20 0.45
CA1 P00915 3/20 0.45
CA2 P00918 3/20 0.45
CA9 Q16790 3/20 0.45
PIK3CA P42336 6/20 0.44
PIK3CD O00329 5/20 0.44
MTOR P42345 3/20 0.42
ROCK2 O75116 2/20 0.41
GHSR Q92847 2/20 0.40
CYP3A4 P08684 2/20 0.38
CYP3A5 P20815 2/20 0.38
KDM4E B2RXH2 2/20 0.37
MEN1 O00255 2/20 0.37
ALDH1A1 P00352 2/20 0.37
MAPT P10636 2/20 0.37
HPGD P15428 2/20 0.37
KMT2A Q03164 2/20 0.37
RXFP1 Q9HBX9 1/20 0.36
HDAC3 O15379 1/20 0.36
HDAC1 Q13547 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8215098 0.91 PIK3CA (0.50) CA12CA1CA2CA9PIK3CA
SCHEMBL11924820 0.89 CA12 (0.45) CA12CA1CA2CA9PIK3CA
SCHEMBL8206190 0.85 PIK3CD (0.43) PIK3CAPIK3CDMTORKDM4EMEN1
SCHEMBL8098332 0.85 PIK3CA (0.48) PIK3CAPIK3CDMTORGHSRMEN1
SCHEMBL8211599 0.84 PIK3CA (0.49) CA12CA1CA2CA9PIK3CA
SCHEMBL8206186 0.84 RAB9A (0.45) CA12CA1CA2CA9PIK3CA
SCHEMBL8091889 0.82 PIK3CA (0.48) PIK3CAPIK3CDMTORGHSRKDM4E
SCHEMBL8098323 0.82 POLB (0.43) PIK3CAPIK3CDMTORKDM4EMEN1
SCHEMBL11925866 0.82 PIK3CA (0.48) CA12CA1CA2CA9PIK3CA
SCHEMBL8098329 0.82 PIK3CA (0.55) PIK3CAPIK3CDMTOR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009007748-A2 TRISUBSTITUTED PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES ASTRAZENECA AB (SE) 2009-01-15 WO disclosed